Edit |   |
---|---|
Antigenic Specificity | CD309, Human (Ramucirumab biosimilar) |
Clone | Ramucirumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD309 Recombinant Antibody (Ramucirumab). Ramucirumab (LY3009806, IMC-1121B, trade name Cyramza) is a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors. This drug was developed by ImClone Systems Inc |
Immunogen | n/a |
Other Names | Anti-CD309 Recombinant Antibody, Research Grade Ramucirumab, Anti-Human CD309 Recombinant Antibody(Ramucirumab), 1121B, IMC-1121B, LY3009806, Antibody Drug Analogues, Monoclonal Antibody, YR1195, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 15966-93-5 |
Catalog # | YR1195 |
Price | please inquire |
Order / More Info | CD309, Human (Ramucirumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |